Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey

G. Ferron 1, * L. Simon 1 F. Guyon 2 O. Glehen 3, 4 D. Goéré 5 D. Elias 5 M. Pocard 6 L. Gladieff 7 J.M. Bereder 8 C. Brigand 9 J.M. Classe 10 J.M. Guilloit 11 F. Quenet 12, 13 K. Abboud 14 C. Arvieux 15 F. Bibeau 13, 12 C. de Chaisemartin 16 D. Delroeux 17 S. Durand-Fontanier 18 N. Goasguen 19 L. Gouthi 20 B. Heyd 17 R. Kianmanesh 21 E. Leblanc 22 V. Loi 23 G. Lorimier 24 F. Marchal 25 P. Mariani 26 C. Mariette 27 P. Méeus 28 S. Msika 29 P. Ortega-Deballon 30 J. Paineau 10 D. Pezet 31 G. Piessen 27 N. Pirro 32 C. Pomel 33 J. Porcheron 14 G. Pourcher 34 P. Rat 30 J.M. Regimbeau 35 C. Sabbagh 35 E. Thibaudeau 10 J.J. Torrent D. Tougeron 36 J.J. Tuech 37 F. Zinzindohoue 38 P. Lundberg 4 F. Herin 39 L. Villeneuve 40
* Auteur correspondant
Abstract : BACKGROUND: Over the last two decades, many surgical teams have developed programs to treat peritoneal carcinomatosis with extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Currently, there are no specific recommendations for HIPEC procedures concerning environmental contamination risk management, personal protective equipment (PPE), or occupational health supervision. METHODS: A survey of the institutional practices among all French teams currently performing HIPEC procedures was carried out via the French network for the treatment of rare peritoneal malignancies (RENAPE). RESULTS: Thirty three surgical teams responded, 14 (42.4%) which reported more than 10 years of HIPEC experience. Some practices were widespread, such as using HIPEC machine approved by the European Community (100%), individualized or centralized smoke evacuation (81.8%), "open" abdominal coverage during perfusion (75.8%), and maintaining the same surgeon throughout the procedure (69.7%). Others were more heterogeneous, including laminar flow air circulation (54.5%) and the provision of safety protocols in the event of perfusate spills (51.5%). The use of specialized personal protective equipment is ubiquitous (93.9%) but widely variable between programs. CONCLUSION: Protocols regarding cytoreductive surgery/HIPEC and the associated professional risks in France lack standardization and should be established.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-02334165
Contributeur : Amandine Michel-Avella <>
Soumis le : vendredi 25 octobre 2019 - 18:08:12
Dernière modification le : mercredi 4 décembre 2019 - 09:48:02

Identifiants

Citation

G. Ferron, L. Simon, F. Guyon, O. Glehen, D. Goéré, et al.. Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey. EJSO - European Journal of Surgical Oncology, WB Saunders, 2015, 41 (10), pp.1361-1367. ⟨10.1016/j.ejso.2015.07.012⟩. ⟨hal-02334165⟩

Partager

Métriques

Consultations de la notice

37